Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

N.Y. Attorney General Seeks Information On Wholesaler Deals With Secondary Market

This article was originally published in The Pink Sheet Daily

Executive Summary

Pharmaceutical wholesalers including Cardinal, ABC are subpoenaed by AG Eliot Spitzer's office in an inquiry into the wholesale secondary market, which has been associated with counterfeiting. The three top wholesalers have previously stated their intentions to cut back on secondary purchases.

You may also be interested in...



New York AG’s Inquiry Into Pharmaceutical Trading Practices Continues Following Cardinal Settlement

As part of the agreement, the firm is required to enter “Wholesaler Safe Product Practice” agreement.

New York AG’s Inquiry Into Pharmaceutical Trading Practices Continues Following Cardinal Settlement

As part of the agreement, the firm is required to enter “Wholesaler Safe Product Practice” agreement.

CVS Pushes Drug Wholesalers To Drop Secondary Market Purchases

CVS will no longer purchase pharmaceuticals from distributors that participate in the secondary wholesale market. Each of the top three wholesalers purchases about 0.5% of its drugs from sources other than the manufacturer.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel